Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
This trial will assess the efficacy of CRx-401 in lowering FPG levels in patients taking metformin to treat their diabetes. In addition, this initial trial will evaluate insulin resistance (HOMA-IR index), HgbA1c levels, glycated protein, LDL, HDL, triglycerides, and total cholesterol, as well as the safety of CRx-401.
Epistemonikos ID: 2fe638649eab1046482e6fcbb8cf671606d1731f
First added on: May 04, 2024